Tumour markers in the detection of opisthorchiasis-associated cholangiocarcinoma.

[1]  D. Ettinger,et al.  Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with 131I anti-CEA--a Radiation Therapy Oncology Group Study. , 1987, International journal of radiation oncology, biology, physics.

[2]  C. W. Chan,et al.  5 Diseases caused by liver flukes and cholangiocarcinoma , 1987 .

[3]  H. Egami,et al.  Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system. , 1987, Gut.

[4]  J. Bidart,et al.  CA 125 (ovarian tumour-associated antigen) in ascitic liver diseases. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[5]  R. Bukowski,et al.  Hepatic artery infusion of 5‐fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma , 1984, Cancer.

[6]  C. Haglund,et al.  Comparison of a new tumour marker, CA 199TM, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases , 2004 .

[7]  Schwartz Da.  Helminths in the induction of cancer: Opisthorchis viverrini, Clonorchis sinensis and cholangiocarcinoma. , 1980 .

[8]  K. Kelly,et al.  Surgical treatment of adenocarcinoma. Location: junction of the right, left, and common hepatic biliary ducts. , 1979, Archives of surgery.

[9]  N. Bhamarapravati,et al.  Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. , 1978, Cancer research.

[10]  D. Sonakul,et al.  Hepatic carcinoma with opisthorchiasis. , 1978, The Southeast Asian journal of tropical medicine and public health.

[11]  T. Stitnimankarn,et al.  Opisthorchiasis: a clinicopathologic study of 154 autopsy cases. , 1978 .